-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Recursion Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and change rate from 2019 to Q3 2025.
- Recursion Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $13.4M, a 227% increase year-over-year.
- Recursion Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending 30 Sep 2025 was $44.8M, a 204% increase year-over-year.
- Recursion Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2024 was $18.8M, a 121% increase from 2023.
- Recursion Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $8.5M, a 2143% increase from 2022.
- Recursion Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $379K, a 24.7% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)